Related Experiment Videos
["IOL has established its status in Japanese ophthalmology"]
Nippon Ganka Gakkai Zasshi
|June 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Brown tumor of the thoracic spine in a patient on long-term hemodialysis.
Clinical nephrology·2001
Hydroxyapatite-coating on titanium arc sprayed titanium implants.
Journal of biomedical materials research·1997
Decentration associated with asymmetric capsular shrinkage and intraocular lens design in a rabbit model.
Journal of cataract and refractive surgery·1995
Prolyl hydroxylase inhibitor and lysyl hydroxylase inhibitor inhibit spreading of corneal epithelium.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·1994
Steroid Resistant Vogt-Koyanagi-Harada Disease Treated Effectively with Cyclosporine.
Nippon Ganka Gakkai zasshi·2018
The Effect of Low-dose Cyclosporine (100 mg Once Daily) for Chronic Vogt-Koyanagi-Harada Disease.
Nippon Ganka Gakkai zasshi·2018
Accelerated Epithelial Proliferation in a Rabbit Model of Bullous Keratopathy.
Nippon Ganka Gakkai zasshi·2018
The Science of Glaucoma Surgery -Filtration Surgery and the Role of Cytokines.
Nippon Ganka Gakkai zasshi·2018
Serological correlates of disseminated Borrelia burgdorferi infection in mouse models of tick challenge.
Microbiology spectrum·2026
IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
[Advances in mechanical signal-regulated tumor immunity and its therapeutic development].
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences·2026
Cytokine-independent activation of STAT5 promotes the persistence and function of CD4+ regulatory T cells.
Molecular therapy. Advances·2026
CAR design equips diverse immune cells with unique antigen-specific activation identities.
Molecular therapy. Oncology·2026